Logo image of ABO.DE

CLEARVISE AG (ABO.DE) Stock Fundamental Analysis

FRA:ABO - DE000A1EWXA4 - Common Stock

1.66 EUR
-0.01 (-0.6%)
Last: 8/28/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ABO scores 3 out of 10 in our fundamental rating. ABO was compared to 19 industry peers in the Independent Power and Renewable Electricity Producers industry. There are concerns on the financial health of ABO while its profitability can be described as average. ABO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ABO had negative earnings in the past year.
In the past year ABO had a positive cash flow from operations.
Of the past 5 years ABO 4 years were profitable.
ABO had a positive operating cash flow in each of the past 5 years.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.37%, ABO is in line with its industry, outperforming 42.11% of the companies in the same industry.
The Return On Equity of ABO (-0.92%) is comparable to the rest of the industry.
The Return On Invested Capital of ABO (0.76%) is worse than 68.42% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ABO is in line with the industry average of 4.57%.
Industry RankSector Rank
ROA -0.37%
ROE -0.92%
ROIC 0.76%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

ABO has a Operating Margin (12.79%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ABO has declined.
ABO has a Gross Margin of 99.48%. This is amongst the best in the industry. ABO outperforms 100.00% of its industry peers.
ABO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.79%
PM (TTM) N/A
GM 99.48%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1

2. Health

2.1 Basic Checks

ABO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ABO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ABO has been increased compared to 5 years ago.
ABO has a worse debt/assets ratio than last year.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ABO has an Altman-Z score of 0.58. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.58, ABO is not doing good in the industry: 68.42% of the companies in the same industry are doing better.
The Debt to FCF ratio of ABO is 12.04, which is on the high side as it means it would take ABO, 12.04 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.04, ABO is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
ABO has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
ABO has a Debt to Equity ratio (1.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 12.04
Altman-Z 0.58
ROIC/WACC0.2
WACC3.76%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ABO has a Current Ratio of 0.81. This is a bad value and indicates that ABO is not financially healthy enough and could expect problems in meeting its short term obligations.
ABO has a worse Current ratio (0.81) than 73.68% of its industry peers.
A Quick Ratio of 0.81 indicates that ABO may have some problems paying its short term obligations.
The Quick ratio of ABO (0.81) is worse than 73.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

The earnings per share for ABO have decreased strongly by -88.89% in the last year.
ABO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.53%.
ABO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.75% yearly.
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%-9.65%

3.2 Future

The Earnings Per Share is expected to grow by 40.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, ABO will show a quite strong growth in Revenue. The Revenue will grow by 10.03% on average per year.
EPS Next Y213.43%
EPS Next 2Y51.42%
EPS Next 3Y40.72%
EPS Next 5YN/A
Revenue Next Year17.02%
Revenue Next 2Y14.18%
Revenue Next 3Y10.03%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

ABO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ABO is valuated quite expensively with a Price/Forward Earnings ratio of 205.45.
Based on the Price/Forward Earnings ratio, ABO is valued a bit more expensive than the industry average as 68.42% of the companies are valued more cheaply.
ABO is valuated expensively when we compare the Price/Forward Earnings ratio to 22.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 205.45
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200

4.2 Price Multiples

ABO's Enterprise Value to EBITDA ratio is in line with the industry average.
89.47% of the companies in the same industry are more expensive than ABO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.38
EV/EBITDA 15.6
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ABO's earnings are expected to grow with 40.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.42%
EPS Next 3Y40.72%

4

5. Dividend

5.1 Amount

ABO has a Yearly Dividend Yield of 3.59%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.53, ABO pays a bit more dividend than its industry peers.
ABO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.59%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y51.42%
EPS Next 3Y40.72%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

CLEARVISE AG

FRA:ABO (8/28/2025, 7:00:00 PM)

1.66

-0.01 (-0.6%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-14 2025-11-14
Inst Owners5.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap125.10M
Analysts85
Price Target3.03 (82.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.59%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.32%
PT rev (3m)-5.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)230.53%
EPS NY rev (3m)230.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.69%
Revenue NY rev (3m)-1.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 205.45
P/S 3.56
P/FCF 7.38
P/OCF 7.38
P/B 0.78
P/tB 0.78
EV/EBITDA 15.6
EPS(TTM)-0.01
EYN/A
EPS(NY)0.01
Fwd EY0.49%
FCF(TTM)0.22
FCFY13.55%
OCF(TTM)0.22
OCFY13.55%
SpS0.47
BVpS2.12
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.37%
ROE -0.92%
ROCE 1.25%
ROIC 0.76%
ROICexc 0.77%
ROICexgc 0.77%
OM 12.79%
PM (TTM) N/A
GM 99.48%
FCFM 48.29%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ROICexc(3y)3.51%
ROICexc(5y)2.93%
ROICexgc(3y)3.54%
ROICexgc(5y)2.98%
ROCE(3y)4.87%
ROCE(5y)4.15%
ROICexcg growth 3Y9.43%
ROICexcg growth 5Y-12.73%
ROICexc growth 3Y10.43%
ROICexc growth 5Y-12.09%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 12.04
Debt/EBITDA 8.79
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 81.44%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 0.58
F-Score3
WACC3.76%
ROIC/WACC0.2
Cap/Depr(3y)122.48%
Cap/Depr(5y)90.46%
Cap/Sales(3y)45.96%
Cap/Sales(5y)37.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y213.43%
EPS Next 2Y51.42%
EPS Next 3Y40.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%-9.65%
Revenue Next Year17.02%
Revenue Next 2Y14.18%
Revenue Next 3Y10.03%
Revenue Next 5YN/A
EBIT growth 1Y-59.38%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year444.54%
EBIT Next 3Y84.01%
EBIT Next 5YN/A
FCF growth 1Y-214.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.76%
OCF growth 3Y-6.75%
OCF growth 5Y-8.15%